Response to Letters Regarding Article, “Using Dabigatran in Patients With Stroke: A Practical Guide for Clinicians”
Mark J. Alberts(Nanotherapeutics (United States)), David García(University of New Mexico), Gerald V. Naccarelli(Clinical Research Institute), Richard A. Bernstein(Northwestern University)
Cited by 1
Related Papers
Association of apolipoprotein E allele ϵ4 with late‐onset familial and sporadic Alzheimer's disease
|Neurology|1993|3.8k
Cryptogenic Stroke and Underlying Atrial Fibrillation
|New England Journal of Medicine|2014|2.2k
Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack
|Stroke|2006|1.9k
Idarucizumab for Dabigatran Reversal — Full Cohort Analysis
|New England Journal of Medicine|2017|1.1k
Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke
|Annals of Neurology|1992|1k